To see the effect of H-009 and Arsenic-sulphuricum-flavum in color change of vitiligo white patches and examining safety in patients
- Conditions
- Health Condition 1: null- vitiligo
- Registration Number
- CTRI/2012/03/002531
- Lead Sponsor
- Homeopathy India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Patients with focal vitiligo. Focal vitiligo This type is characterized by one or more lesions in single area.
Patient is willing and able to give written informed consent
Vitiligo stable since 3 months, that is, there should have been no increase of spots in number or size, during last three months.
Patient having vitiligo spots, size up less than 15cm x 15cm.
Patient having extensive vitiligo, bilateral symmetrical or having onlymuco-cutaneus junction (such as lips, genitals, finger-tips, etc.) affection.
Any form of systemic, injectable or topical treatment (conventional, homeopathic, Ayurvedic, Cuben, Phototheraphy, surgical, laser, etc.) during the last 2 months
Patients having uncontrolled or untreated under active Thyroid. (To be ruled out by TSH study.)
Patient who are on or have consumed in last three months any anti-cancer (conventional) medication.
Women of childbearing age who had tested positive for pregnancy, or who do not use acceptable contraceptive method, or do not agree to practice reliable contraception during the study.
Current Participation or participation in last 3 months period, in any clinical trial.
Any finding of clinical observation (anamnesis and physical exam) laboratory abnormality, disease (for example, liver, cardiovascular system, lung) or therapy that, in opinion of the investigator may endanger the subject or interfere with the endpoints of study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method